| Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets S Takka, S Rajbhandari, A Sakr European journal of pharmaceutics and biopharmaceutics 52 (1), 75-82, 2001 | 169 | 2001 |
| Evaluation of Chitosan/Alginate Beads Using Experimental Design: Formulation and In Vitro Characterization S Takka, A Gürel Aaps Pharmscitech 11, 460-466, 2010 | 161 | 2010 |
| Formulation and investigation of nicardipine HCl–alginate gel beads with factorial design-based studies S Takka, ÖH Ocak, F Acartürk European journal of pharmaceutical sciences 6 (3), 241-246, 1998 | 136 | 1998 |
| Calcium alginate microparticles for oral administration: II: effect of formulation factors on drug release and drug entrapment efficiency F Acarturk, S Takka Journal of microencapsulation 16 (3), 291-302, 1999 | 107 | 1999 |
| In-vitro and In-vivo Evaluation of Mesalazine–Guar Gum Matrix Tablets for Colonic Drug Delivery F Tuğcu-Demiröz, F Acartürk, S Takka, Ö Konuş-Boyunağa Journal of drug targeting 12 (2), 105-112, 2004 | 96 | 2004 |
| Bioavailability file: valsartan M Saydam, S Takka FABAD Journal of Pharmaceutical Sciences 32 (4), 185, 2007 | 86 | 2007 |
| Evaluation of alginate based mesalazine tablets for intestinal drug delivery F Tuğcu-Demiröz, F Acartürk, S Takka, Ö Konuş-Boyunağa European Journal of Pharmaceutics and Biopharmaceutics 67 (2), 491-497, 2007 | 71 | 2007 |
| Development and validation of an in vitro–in vivo correlation for buspirone hydrochloride extended release tablets S Takka, A Sakr, A Goldberg Journal of controlled release 88 (1), 147-157, 2003 | 70 | 2003 |
| Propranolol hydrochloride–anionic polymer binding interaction S Takka Il Farmaco 58 (10), 1051-1056, 2003 | 62 | 2003 |
| Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design TE Yalcin, S Ilbasmis-Tamer, S Takka International journal of pharmaceutics 548 (1), 255-262, 2018 | 55 | 2018 |
| Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo TE Yalcin, S Ilbasmis-Tamer, S Takka International journal of pharmaceutics 580, 119246, 2020 | 47 | 2020 |
| Improving the dissolution of a water-insoluble orphan drug through a fused deposition modelling 3-Dimensional printing technology approach M Saydam, S Takka European Journal of Pharmaceutical Sciences 152, 105426, 2020 | 37 | 2020 |
| Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity TE Yalcin, S Ilbasmis-Tamer, B Ibisoglu, A Özdemir, M Ark, S Takka Pharmaceutical development and technology 23 (1), 76-86, 2018 | 36 | 2018 |
| Investigation of colon-specific dosage forms of ondansetron prepared with natural polymers F Tuğcu-Demiröz, F Acartürk, S Takka Die Pharmazie-An International Journal of Pharmaceutical Sciences 61 (11 …, 2006 | 35 | 2006 |
| Bile salt-reinforced alginate-chitosan beads S Takka, AG Çali Pharmaceutical development and technology 17 (1), 23-29, 2012 | 27 | 2012 |
| Pectin–hydroxypropyl methylcellulose drug delivery system for colon targeting M Türkoglu, S Takka, H Baran, A Sakr Pharm. Ind 61 (7), 662-665, 1999 | 18 | 1999 |
| Development and in vitro evaluation of pH-independent release matrix tablet of weakly acidic drug valsartan using quality by design tools M Saydam, S Takka Drug development and industrial pharmacy 44 (12), 1905-1917, 2018 | 13 | 2018 |
| Formulation and in vitro-in vivo evaluations on sustained release acetylsalicylic acid tablets Y Capan, S Senel, S Calis, S Takka, A Hincal Pharm Ind 51 (4), 443-448, 1989 | 13 | 1989 |
| Effect of roller compaction on nisin raw material lot-to-lot variations WA HABIB, S TAKKA, A SAKR Pharmazeutische Industrie 62 (11), 914-918, 2000 | 7 | 2000 |
| Effect of organic solvents on gemcitabine loaded PLGA nanoparticles TE Yalcin, S Ilbasmis-Tamer, S Takka FABAD Journal of Pharmaceutical Sciences 42 (1), 15, 2017 | 6 | 2017 |
